All News

vaccine.jpg

Herpes Zoster Vaccine Update

d Cassandra Calabrese, DO

Shingrix (GSK), the herpes zoster subunit vaccine (a two-shot series), was approved by the FDA in Fall 2018 and is currently approved for use in adults 50 years and older.

Read Article
podcastLogo-01%20RESIZED.jpg

RheumNow Podcast –Favorites of ACR 2019 (11.22.19)

d Jack Cush, MD

Dr. Jack Cush recaps standout presentations and information from ACR 2019 held in Atlanta November 9-12, 2019.

Read Article
woman-1284353_640.jpg

A Focus on WOCBA (Women of Childbearing Age)

d Maeve Gamble, MD

Largely because it can be difficult to do studies in pregnant women, gaps remain in the area of rheumatic disease in pregnancy. This year’s ACR highlights some important new points to consider.

Read Article
Convention2.jpg

ACR 2019 - Report From Day 3 (Tuesday)

d Jack Cush, MD

Here's my summary of key studies presented Tuesday. 



Tofacitinib in Polyarticular JIA

Read Article
ACRmtg.jpg (keep)

Psoriatic Arthritis at ACR 2019

d Jack Cush, MD

Below are several of the highlight studies in psoriatic arthritis (PsA) presented at the ACR 2019 annual meeting in Atlanta. 

Read Article
dumbbells-2465478_640.jpg

Muscle Loss and Frailty in Rheumatic Disease

d Paul Sufka, MD

At the 2019 ACR annual meeting, several abstracts looked at the importance of myopia (muscle wasting due to illness at any age) and sarcopenia (age related muscle wasting) in the setting of various rheumatologic diseases.

Read Article
acr_session2.jpeg

ACR 2019 - Report From Day 2 (Monday)

d Jack Cush, MD

Monday was another full day of sessions and studies here in Atlanta. Following is my roundup of day two.

The Safety of Methotrexate

Read Article
influenza-156098_640.png

Influenza Vaccine Updates And Pearls At ACR 2019

d Cassandra Calabrese, DO

As we enter flu season it is of the utmost importance that we remember to assess our patients’ influenza vaccine status at each visit.

Read Article
gout.MTP_.jpg

PANLAR Ultrasound Study Group: Recommendations On Imaging Modalities In Gout

d Olga Petryna, MD

Gout is a systemic inflammatory disease with high potential for joint damage due to erosive changes and MSU deposits resulting in disability and chronic pain. Prompt diagnosis and effective treatment are key to better long term outcomes and decreased disability.

Read Article
Conv3.jpg

ACR 2019 – Best of the Plenary Sessions

d Jack Cush, MD

The ACR Plenary Sessions featured some of the best research presented on Sunday, Monday, and Tuesday in Atlanta. Here are my seven notable highlights from the Plenaries.

Read Article
vasculitis.digitial.jpg

Hepatitis C-Related Cryoglobulinemic Vasculitis

d David Liew, FRACP

Flares of vasculitis can still be a problem after hepatitis C-related cryoglobulinemic vasculitis patients are cured of their hepatitis C by direct-acting antivirals, as demonstrated by data from four registries presented at ACR 2019 in Atlanta, Georgia.

Read Article
It's Dr. Paul Sufka @psufka talking about methotrexate and prednisone for Hand osteoarthritis https://t.co/fnvIs3LnYs #ACR19 @philipcrobinson

Links:

Dr. John Cush RheumNow ( View Tweet)

The draft 2020 ACR #gout guidelines were presented at the last slot of the meeting. Big changes for ULT initiation #ACR19 @philipcrobinson [Slides attached] https://t.co/4g3YUlm7Sa

Links:

Dr. John Cush RheumNow ( View Tweet)

Long term results for GCA pts on TCZ (GiACTA): No new safety signals. Nearly 50% of those on TCZ QW maintained remission. Flares noted in PBO/ cessation TCZ and remission restored in majority once TCZ restarted. https://t.co/DN6TWYgWsH Plenary abs #808 #ACR19 @uptoTate

Links:

Dr. John Cush RheumNow ( View Tweet)

99mTc-maraciclatide (which binds integrins) whole body imaging has similar uptake to PDUS evaluation for synovial inflammation. It is quick, and widely available. Cost may be prohibitive, however. Abstract #286 https://t.co/4LqrzcoA9U #ACR19 @uptoTate

Links:

Dr. John Cush RheumNow ( View Tweet)

ACR has released 3 FREE "SPOTLIGHT" Slide Decks on RA, SLE, SpA; ~15 slides each deck; compilations of cool abstracts presented at #ACR19. Use the link supplied below https://t.co/CsKVMDoGoL

Links:

Dr. John Cush RheumNow ( View Tweet)

FINCH3: FILGOTINIB studied in this cohort naive to MTX; interesting that safety data looks good! Maybe too early to tell. Abst# 927 https://t.co/AonswiGYG3 https://t.co/q3OU582WbT

Links:

Dr. John Cush RheumNow ( View Tweet)
abstr#0848 - Retrospective study Medicare database to evaluat outcomes of chronic low dose steroids (GCs) in Rheum Dz: n= 246,297, 47% on GCs. Pts on steroids have : 1. ⬆️ use of narcotics (pain) 2. RA 3. ⬆️hosp visits related to infx 4. Less f/u https://t.co/xD8isyKZsz

Links:

Dr. John Cush RheumNow ( View Tweet)

Plenary session shows AA/blacks at higher risk for #SLE & that blacks have 16 fold increased risk for IHD, CVD. CV risk accelerated at yrs 1 & 10. Copy & paste. #ACR19 Abst 805 https://t.co/pW8JdGxCUf https://t.co/lLPTnyTa2z

Links:

Dr. John Cush RheumNow ( View Tweet)
Abstr#1898 #acr19 @kDAO2011. Danish prospective RA registry of pregnancy & offspring n= 816 - kids of moms w/ RA performed a little worse in math grades 2,4,6, 8 compared to peers regardless of maternal seropositivity. No influence by paternal RA. https://t.co/bOBDtjVtfm

Links:

Dr. John Cush RheumNow ( View Tweet)

×